MedTrace Logo

Observational Study on Patients With Hepatocellular Carcinoma (HCC)

NCT04021056 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2019-07-16

No results posted yet for this study

Summary

This is an ongoing, longitudinal, single centre, observational, retro-prospective clinical cohort study of patients with HCC in usual clinical practice. All the HCC patients diagnosed and treated in Liver Cancer Center, Nanfang Hospital are consecutively collected and followed up.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2019-08-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021056 on ClinicalTrials.gov